On-Demand Webinar
CGM, BGM, or Both? How to Choose the Right Glucose Monitoring Approach for Your Clinical Trial
As glucose monitoring becomes more central to clinical trial endpoints and patient safety, selecting the right blood glucose monitoring device isn’t just a data decision. It’s a strategic choice that affects cost, compliance, and, ultimately, the participants.
In this on-demand webinar, YPrime experts break down the real-world tradeoffs of CGM vs BGM across a range of therapeutic areas. You’ll explore how these tools shape patient experience, data integrity, and trial execution—especially when paired with eCOA and connected device strategies.
Whether your study focuses on GLP-1, cardiometabolic, PCOS, NASH, or other emerging indications, this session offers practical guidance to help you align your glucose monitoring approach in clinical trials with your protocol and population needs.
What You’ll Learn
Watch the On-Demand Webinar
Fill out the form to access the full session and gain expert insights on glucose monitoring and eCOA integration in today’s most complex trials.
Want to dive deeper into device strategy? Download our eCOA + Connected Devices Playbook for practical guidance on integrating wearables and glucose monitoring into your studies.